Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell, Skin”

757 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 757 results

Not applicableUnknownNCT02352428
What this trial is testing

Skin Cancer Screening Education Study

Who this might be right for
Skin TumorsMelanomaBasal Cell Carcinoma+1 more
Association of Dermatological Prevention, Germany 113
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Not applicableUnknownNCT05340543
What this trial is testing

Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)

Who this might be right for
Cutaneous TumorOptical Coherence TomographyBasal Cell Carcinoma+2 more
Ramsay Générale de Santé 150
Testing effectiveness (Phase 2)WithdrawnNCT00605709
What this trial is testing

Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
BPGbio
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Looking for participantsNCT07070518
What this trial is testing

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more
GV20 Therapeutics 350
Early research (Phase 1)Ended earlyNCT02890368
What this trial is testing

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Who this might be right for
Solid TumorsMycosis FungoidesMelanoma+5 more
Pfizer 56
Not applicableActive Not RecruitingNCT03412058
What this trial is testing

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
UNICANCER 670
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Not applicableUnknownNCT05845632
What this trial is testing

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellSkin CancerCarcinoma, Squamous Cell, Skin+3 more
Maastricht University Medical Center 965
Not applicableActive Not RecruitingNCT06046625
What this trial is testing

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma+8 more
Maastricht University Medical Center 15
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Looking for participantsNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT04632433
What this trial is testing

Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Fondazione Melanoma Onlus 25
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 520
Testing effectiveness (Phase 2)Looking for participantsNCT06974604
What this trial is testing

Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM

Who this might be right for
Breast NeoplasmsLung Neoplasms
Brown University 60
Load More Results